Ground EMS Blood Transfusion Programs Surpass 400 Agencies Nationwide

Blood on Board: A Lifesaving Standard EMS Can't Yet Afford

There's a quiet revolution happening on the back of ambulances across America. According to the Prehospital Blood Transfusion Coalition, more than 400 ground 911 EMS agencies now carry blood products to the scene — up from roughly five agencies in 2016. That trajectory tells you everything about where prehospital medicine is heading, and very little about how hard it is to actually get there.

The clinical case is no longer in question. Hemorrhage is the leading cause of preventable death in trauma, and a striking share of those patients die before they ever reach a hospital. The Coalition notes that over 10,000 Americans die each year from severe blood loss, often within minutes — and that nearly half of seriously injured bleeding patients die before arrival. Add postpartum hemorrhage, GI bleeds, and other time-critical bleeding emergencies, and the population that benefits from blood "on board" is far larger than trauma alone. After years of military and civilian evidence, the intervention is proven. Yet fewer than 3% of eligible agencies carry blood today.

So why isn't blood everywhere?

The honest answer isn't clinical hesitation — it's economics. As Coalition Chair Jon Krohmer, M.D., frames it, the barriers come down largely to funding and logistics. Standing up and sustaining a blood program is expensive: cold-chain storage and monitoring, training, quality assurance, hospital partnerships to rotate units before they expire, and the cost of the blood products themselves. Crucially, those product costs generally aren't reimbursed by insurance. A program can do everything right clinically and still be underwater financially.

This is where the reimbursement math becomes painful for EMS leaders. Even when a blood-administering call qualifies at the highest ground transport level — ALS2 — the reimbursement doesn't come close to covering the true cost of carrying and delivering blood. ALS2 was never designed to fund a blood program. It reflects a higher acuity transport, not the carrying cost of a refrigerated, perishable, rotated inventory of one of the most precious and regulated supplies in medicine. So agencies are left absorbing the gap, leaning on grants, hospital partnerships, and community support to keep the cooler stocked. The Coalition is actively developing a CMS reimbursement proposal and pursuing policy recommendations for Congress and state decision-makers — important work, but a reimbursement pathway that arrives "eventually" doesn't pay for the unit transfused this week.

The margin problem behind the mission

Here's the uncomfortable truth that doesn't make it into many press releases: an EMS agency can be clinically excellent and mission-driven and still be unable to afford to do the right thing. Every dollar lost to underpayment, denied claims, slow reimbursement, or administrative overhead is a dollar that can't go toward a blood program, a new monitor, or another paramedic. When the highest-acuity calls — the very ones where blood saves a life — don't reliably cover their own cost, financial sustainability stops being a back-office concern and becomes a patient-care concern.

That reframes the conversation for EMS leadership. If new reimbursement for blood is years away, the most controllable lever agencies have right now is the efficiency and accuracy of their existing revenue cycle. You can't change the ALS2 rate today, but you can change how much of what you're actually owed you successfully capture — and how much it costs you to capture it.

Where technology fits the equation

This is the part of the story we think deserves more attention. Lowering the cost of getting paid is one of the few near-term ways agencies can free up the margin that ambitious clinical programs require.

At MP Cloud, this is the problem we work on every day. Modern billing platforms and AI-enabled workflows can reduce the manual labor behind every claim — automating documentation review, flagging errors and missing information before a claim goes out, accelerating clean-claim submission, and reducing the denials and rework that quietly erode revenue. The goal isn't just to bill faster; it's to lower the per-claim cost of billing so that more of each reimbursement dollar actually reaches the agency, and fewer staff hours are spent chasing payments instead of supporting operations.

We're not suggesting that smarter billing replaces the policy fight for blood reimbursement — it doesn't, and that advocacy matters enormously. But when the reimbursement environment is stacked against you, operational and financial efficiency is how forward-leaning agencies create the headroom to invest in programs like prehospital blood while the policy catches up.

The bottom line

Four hundred agencies carrying blood is a milestone worth celebrating, and the survivors behind that number are the reason this work matters. But scaling from 3% of eligible agencies to something approaching a national standard won't happen on clinical evidence alone. It will happen when EMS agencies can afford to say yes — when the economics of running an EMS organization are strong enough to support the medicine its clinicians already know how to deliver.

Until reimbursement reform arrives, the agencies that thrive will be the ones that treat financial efficiency as a clinical enabler. Lowering the cost of billing isn't the headline — saving lives is. But one increasingly makes the other possible.